JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banks, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banks, W. A.

Vol. 291, Issue 2, 665-670, November 1999

Characterization of Interleukin-1alpha Binding to Mouse Brain Endothelial Cells1

William A. Banks

Geriatrics Research Educational and Clinical Center, Veterans Affairs Medical Center-St. Louis and Division of Geriatrics, Department of Internal Medicine, Saint Louis University, St. Louis, Missouri

In vivo studies have shown that interleukin (IL)-1alpha binds to and is transported across brain endothelial cells, whereas in vitro studies have shown that brain endothelial cells respond to IL and contain mRNA for the IL-type 1 receptor. However, these binding sites have yet to be characterized. Herein, we used murine brain microvessels to characterize the binding of IL labeled with 125I. Binding was temperature- and time-dependent with maximal binding after 4 h of incubation at 37°C. The amount of radioactivity determined by HPLC to represent intact 125I-labeled murine IL-1alpha at 4 h was ~100% in the incubation fluid and 80 to 90% for radioactive material recovered from the incubated cells. Bmax was 0.955 fmol and the Kd was 292 pM for human 125I-IL and binding was displaced by interleukin-1beta and interleukin-1 receptor antagonist but not by tumor necrosis factor alpha . Binding was dependent on magnesium and glucose. Incubation with antibodies showed that the binding site was not identical with the IL-type 1 receptor but closely resembled the blood-brain barrier transporter. These results show that murine brain endothelial cells have specific binding sites for IL and that these sites more closely resemble the transporter than the type 1 receptor.


0022-3565/99/2912-0665$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Quiniou, P. Sapieha, I. Lahaie, X. Hou, S. Brault, M. Beauchamp, M. Leduc, L. Rihakova, J.-S. Joyal, S. Nadeau, et al.
Development of a Novel Noncompetitive Antagonist of IL-1 Receptor
J. Immunol., May 15, 2008; 180(10): 6977 - 6987.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. M. Hileman, D. D. Pierroz, H. Masuzaki, C. Bjorbak, K. El-Haschimi, W. A. Banks, and J. S. Flier
Characterizaton of Short Isoforms of the Leptin Receptor in Rat Cerebral Microvessels and of Brain Uptake of Leptin in Mouse Models of Obesity
Endocrinology, March 1, 2002; 143(3): 775 - 783.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.